刺槐素通过调控尿酸转运蛋白和NF-κB/NLRP3信号通路改善高尿酸血症

被引:2
作者
吴选霞 [1 ]
补娟 [1 ]
叶勒丹马汉 [1 ]
张胜男 [2 ]
张晓玲 [1 ]
周玲 [1 ]
机构
[1] 新疆维吾尔自治区人民医院
[2] 新疆大学生命科学院
关键词
高尿酸血症; 刺槐素; 尿酸转运蛋白; 核转录因子(NF)-κB/核苷酸寡聚化结构域样受体热蛋白结构域相关蛋白3(NLRP3)信号通路; 炎症;
D O I
10.13422/j.cnki.syfjx.20241711
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的:探讨刺槐素对高尿酸血症(HUA)小鼠的降尿酸作用及其潜在机制。方法:采用氧嗪酸钾和腺嘌呤联合建立HUA小鼠模型。将48只雄性昆明小鼠随机分为6组,正常组,模型组,刺槐素低、中、高剂量(12.5、25、50 mg·kg-1)组和别嘌呤醇组(10 mg·kg-1),连续灌胃给药21 d。采用全自动生化分析仪检测小鼠血清尿酸(UA)、肌酐(Cr)、尿素氮(BUN)、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平。通过酶联免疫吸附测定法(ELISA)检测小鼠肝脏组织黄嘌呤氧化酶(XOD)活性,血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β和IL-18水平。采用苏木素-伊红(HE)染色观察小鼠肾脏组织病理改变。通过蛋白免疫印迹法(Western blot)检测小鼠肾脏组织中葡萄糖转运蛋白9(GLUT9)、尿酸转运蛋白1(URAT1)、磷酸化NF-κB p65蛋白(p-NF-κB p65)和核苷酸寡聚化结构域样受体热蛋白结构域相关蛋白3(NLRP3)水平。结果:与正常组比较,模型组小鼠的UA、Cr、BUN、ALT和AST水平显著升高,肝脏组织XOD活性增加,TNF-α、IL-1β和IL-18水平升高,肾脏组织GLUT9、URAT1、p-NF-κB p65和NLRP3蛋白水平显著增高(P<0.01);与模型组比较,刺槐素呈剂量依赖性地降低小鼠血清UA水平,显著改善肝、肾功能(P<0.05),降低肝脏组织XOD活性(P<0.01),改善肾脏病理状态,下调肾脏组织GLUT9、URAT1、p-NF-κB p65和NLRP3蛋白水平(P<0.01),降低血清炎症因子TNF-α、IL-1β和IL-18水平(P<0.01)。结论:刺槐素可以通过减少尿酸生成、增加尿酸排泄及抑制NF-κB/NLRP3信号通路来改善HUA。因此,刺槐素可能是一种治疗HUA的潜在药物。
引用
收藏
页码:191 / 198
页数:8
相关论文
共 42 条
[1]
1985-2018年中国大陆成人高尿酸血症患病率变化趋势初步研究 [D]. 
严楠 .
北京协和医学院,
2018
[2]
Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure-activity relationship and molecular docking studies (2018-2024) [J].
Singh, Arshdeep ;
Debnath, Rabin ;
Chawla, Viney ;
Chawla, Pooja A. .
RSC MEDICINAL CHEMISTRY, 2024, 15 (06) :1849-1876
[3]
Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice..[J].Qiong Fu;Jin Juan Zhang;Qin Feng Zhu;Ling Ling Yu;Fang Wang;Jing Li;Xun He;Jun Li Ao;Guo Bo Xu;Mao Chen Wei;Xing Jiang Liao;Shang Gao Liao.Biochemical and biophysical research communications.2024,
[4]
Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation.[J].Juan Bu;Yeledan Mahan;Shengnan Zhang;Xuanxia Wu;Xiaoling Zhang;Ling Zhou;Yanmin Zhang.Frontiers in Pharmacology.2024,
[5]
NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective [J].
Alrouji, Mohammed ;
Al-kuraishy, Hayder M. ;
Al-Gareeb, Ali I. ;
Alexiou, Athanasios ;
Papadakis, Marios ;
Jabir, Majid S. ;
Saad, Hebatallah M. ;
Batiha, Gaber El-Saber .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (13) :1775-1789
[6]
Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-KB Signaling Pathway [J].
Yang, Bendong ;
Xin, Meiling ;
Liang, Shufei ;
Huang, Yuhong ;
Li, Jingda ;
Wang, Chao ;
Liu, Chao ;
Song, Xinhua ;
Sun, Jinyue ;
Sun, Wenlong .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2022, 71 (03) :1434-1446
[7]
Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease [J].
Wang, Miao ;
Lin, Xin ;
Yang, Xiaoming ;
Yang, Yanlang .
RENAL FAILURE, 2022, 44 (01) :615-624
[8]
New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds [J].
Yang, Bendong ;
Xin, Meiling ;
Liang, Shufei ;
Xu, Xiaoxue ;
Cai, Tianqi ;
Dong, Ling ;
Wang, Chao ;
Wang, Meng ;
Cui, Yuting ;
Song, Xinhua ;
Sun, Jinyue ;
Sun, Wenlong .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[9]
A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia [J].
Yuan, Qianghua ;
Cheng, Yuan ;
Sheng, Rong ;
Yuan, Yan ;
Hu, Mei .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[10]
The Prevalence of Hyperuricemia and Its Correlates among Adults in China: Results from CNHS 2015-2017 [J].
Piao, Wei ;
Zhao, Liyun ;
Yang, Yuxiang ;
Fang, Hongyun ;
Ju, Lahong ;
Cai, Shuya ;
Yu, Dongmei .
NUTRIENTS, 2022, 14 (19)